NCM
CRVS icon

Northwest Capital Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Northwest Capital Management’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$26.2K Hold
3,397
– – 0.11% 78
2025
Q3 		$25K Hold
3,397
– – 0.03% 154
2025
Q2 		$13.6K Hold
3,397
– – 0.01% 250
2025
Q1 		$10.8K Hold
3,397
– – ﹤0.01% 311
2024
Q4 		$18.2K Hold
3,397
– – 0.01% 263
2024
Q3 		$17.9K Hold
3,397
– – 0.01% 269
2024
Q2 		$6.18K Hold
3,397
– – ﹤0.01% 345
2024
Q1 		$6.05K Hold
3,397
– – ﹤0.01% 430
2023
Q4 		$5.98K Hold
3,397
– – ﹤0.01% 424
2023
Q3 		$4.96K Hold
3,397
– – ﹤0.01% 424
2023
Q2 		$7.78K Buy
+3,397
New +$7.06K ﹤0.01% 400

Other funds holding CRVS

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northwest Capital Management's CRVS Position: Q4 2025 in Review

Northwest Capital Management held its Corvus Pharmaceuticals (CRVS) position steady in Q4 2025 at 3,397 shares worth $26.2K. The position accounts for 0.11% of the portfolio, ranked #78.

Northwest Capital Management first reported a position in CRVS in Q2 2023 and has held it in 11 quarters since. 124 funds tracked by Wall St. Rank hold CRVS as of Q4 2025.

  • Northwest Capital Management held 3,397 shares of Corvus Pharmaceuticals worth $26.2K as of Q4 2025.
  • Northwest Capital Management left its Corvus Pharmaceuticals share count unchanged in Q4 2025.
  • Corvus Pharmaceuticals made up 0.11% of Northwest Capital Management's portfolio in Q4 2025, its #78 holding.
  • Northwest Capital Management first reported a position in Corvus Pharmaceuticals in Q2 2023 and has held it in 11 quarters since.
  • 124 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q4 2025.

Based on Northwest Capital Management's 13F filing for Q4 2025, filed 26 Jan 2026.